Granulocyte-colony-stimulating factor (G-CSF), granulocyte–macrophage colony-stimulating factor (GM-CSF), and pegylated G-CSF are effective at reducing risk and duration of neutropenia-related negative events [3, 4]. The gene discussed is CSF3; the disease is neutropenia.